Mercury Biopharmaceutical Corporation (6932.TWO)

TWD 13.3

(-2.56%)

EBITDA Summary of Mercury Biopharmaceutical Corporation

  • Mercury Biopharmaceutical Corporation's latest annual EBITDA in 2023 was -39.03 Million TWD , down -38.9% from previous year.
  • Mercury Biopharmaceutical Corporation's latest quarterly EBITDA in 2024 Q2 was -8.85 Million TWD , down -3.22% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported an annual EBITDA of -28.1 Million TWD in 2022, down -549.63% from previous year.
  • Mercury Biopharmaceutical Corporation reported an annual EBITDA of -4.32 Million TWD in 2021, down -1960.0% from previous year.
  • Mercury Biopharmaceutical Corporation reported a quarterly EBITDA of -8.58 Million TWD for 2024 Q1, up 30.19% from previous quarter.
  • Mercury Biopharmaceutical Corporation reported a quarterly EBITDA of -9.05 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Mercury Biopharmaceutical Corporation (2023 - 2019)

Historical Annual EBITDA of Mercury Biopharmaceutical Corporation (2023 - 2019)

Year EBITDA EBITDA Growth
2023 -39.03 Million TWD -38.9%
2022 -28.1 Million TWD -549.63%
2021 -4.32 Million TWD -1960.0%
2020 -210 Thousand TWD 0.0%
2019 - TWD 0.0%

Peer EBITDA Comparison of Mercury Biopharmaceutical Corporation

Name EBITDA EBITDA Difference
Allied Biotech Corporation 204.79 Million TWD 119.06%
GeneFerm Biotechnology Co., Ltd. 231.09 Million TWD 116.891%
Easywell Biomedicals, Inc. -85.5 Million TWD 54.347%
TTY Biopharm Company Limited 1.52 Billion TWD 102.561%
Synmosa Biopharma Corporation 1 Billion TWD 103.87%
Orient EuroPharma Co., Ltd. 582.93 Million TWD 106.696%
Center Laboratories, Inc. -175.17 Million TWD 77.717%
Tien Liang BioTech Co., Ltd. 31.04 Million TWD 225.721%
Orient Pharma Co., Ltd. 172.39 Million TWD 122.642%
InnoPharmax Inc. -62.12 Million TWD 37.164%
Johnson Chemical Pharmaceutical Works Co., Ltd. 126.67 Million TWD 130.814%
Excelsior Biopharma Inc. -29.36 Million TWD -32.909%
DV Biomed Co., Ltd. 407.64 Million TWD 109.576%
Foresee Pharmaceuticals Co., Ltd. -912.16 Million TWD 95.721%
Handa Pharmaceuticals, Inc. 802.78 Million TWD 104.862%
UniPharma Co., Ltd. -16.25 Million TWD -140.15%
Anxo Pharmaceutical Co., Ltd. 131.31 Million TWD 129.727%
Alar Pharmaceuticals Inc. 394.52 Million TWD 109.894%
Winston Medical Supply Co., Ltd. 228.32 Million TWD 117.096%
Bioray Biotech Co., Ltd 12.13 Million TWD 421.665%
TSH Biopharm Corporation Limited 99.35 Million TWD 139.289%